Search

Vivien Mak

from San Jose, CA
Age ~48
Get Report
Also known as:
Vivien Mak Or, Mak Y Vivien, Vivien Y Orma, Vivien L Mak, Vivien K
Related to:
James J Reyes, 63Josephine Umpa, 70Anthony Stevenson, 78Rodrigo Cabugos, 68Vivian Cabugos, 69John Reyes, 67
Connected to:
Alla Mak, 75Andy W Mak, 72Anselm J Mak, 33Audrey K Mak, 75Billy M Mak, 77Caroline L Mak, 58Catherine Y Mak, 71Chan C Mak, 74Dave S Mak, 58Doris B Mak, 69

Vivien Mak Phones & Addresses

  • San Jose, CA
  • San Francisco, CA

Resumes

Resumes

Vivien Mak Photo 1

President

View page
Location:
Palo Alto, CA
Industry:
Pharmaceuticals
Work:
Phalanbio
President
Pharmaceutical Consultant 2007 - 2012
Principal
Cellegy Pharmaceuticals 1996 - 2006
Vice President Research
Denovo Ventures Llc 1994 - 1995
Vice President Research
Pharmatrix 1992 - 1993
Director Biopharmaceutical Sciences
Education:
University of California, San Francisco 1987 - 1989
Purdue University 1980 - 1986
Doctorates, Doctor of Philosophy Chung Yuan University
Bachelors, Bachelor of Science
Skills:
Clinical Development
Biotechnology
Drug Delivery
Drug Discovery
Pharmaceutical Industry
Technology Transfer
Clinical Trials
Drug Development
Biopharmaceuticals
Ind
Clinical Research
R&D
Pharmacology
Fda
Formulation
Life Sciences
Regulatory Submissions
Pharmaceutics
Regulatory Affairs
In Vitro
Medical Devices
Gmp
Oncology
In Vivo
Glp
Strategy
Hplc
Languages:
Mandarin
Vivien Mak Photo 2

Vivien Mak

View page
Location:
San Francisco, CA
Industry:
Pharmaceuticals

Business Records

Name / Title
Company / Classification
Phones & Addresses
Vivien Mak
President
PHALANXBIO, INC
6150 Lusk Blvd B-100, San Diego, CA 92121
6150 Lusk Blvd, San Diego, CA 92121
1301 Shoreway Rd, Belmont, CA 94002
1400 Page Ml Rd, Palo Alto, CA 94304
(650) 320-4996

Publications

Us Patents

Compositions And Methods For The Treatment Of Anorectal Disorders

View page
US Patent:
6395736, May 28, 2002
Filed:
Dec 13, 1999
Appl. No.:
09/460306
Inventors:
Thomas P. Parks - San Mateo CA
Vivien Mak - Palo Alto CA
Jung-Chung Lee - Sunnyvale CA
Charles Lee - Union City CA
Assignee:
Cellegy Pharmaceuticals, Inc. - So. San Francisco CA
International Classification:
A61K 3150
US Classification:
514248, 514273, 514353, 514309, 514422
Abstract:
Compositions and methods for the treatment of anorectal disorders are provided in which certain combinations of NO donors, PDE inhibitors, superoxide (O ) scavengers, -adrenergic agonists, cAMP-dependent protein kinase activators, -adrenergic antagonists, L-type Ca channel blockers, estrogens, ATP-sensitive K channel activators and smooth muscle relaxants are used.

Compositions And Methods For The Treatment Of Anorectal Disorders

View page
US Patent:
6627632, Sep 30, 2003
Filed:
Jul 30, 2001
Appl. No.:
09/919590
Inventors:
Thomas P. Parks - San Mateo CA
Vivien Mak - Palo Alto CA
Jung-Chung Lee - Sunnyvale CA
Charles Lee - Union City CA
Assignee:
Cellegy Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K 3150
US Classification:
51425219, 514509
Abstract:
Compositions and methods for the treatment of anorectal disorders are provided in which certain combinations of NO donors, PDE inhibitors, superoxide (O ) scavengers, -adrenergic agonists, cAMP-dependent protein kinase activators, -adrenergic antagonists, L-type Ca channel blockers, estrogens, ATP-sensitive K channel activators and smooth muscle relaxants are used.

Compositions And Methods For The Treatment Of Anorectal Disorders

View page
US Patent:
20010012856, Aug 9, 2001
Filed:
Jan 23, 2001
Appl. No.:
09/769621
Inventors:
Thomas Parks - San Mateo CA, US
Vivien Mak - Palo Alto CA, US
Jung-Chung Lee - Sunnyvale CA, US
Charles Lee - Union City CA, US
Assignee:
Cellegy Pharmaceuticals, Inc.
International Classification:
A61K038/44
A61K031/21
A61K031/195
US Classification:
514/509000, 424/094400, 514/565000
Abstract:
Compositions and methods for the treatment of anorectal disorders are provided in which certain combinations of NO donors, PDE inhibitors, superoxide (O) scavengers, -adrenergic agonists, cAMP-dependent protein kinase activators, -adrenergic antagonists, L-type Ca channel blockers, estrogens, ATP-sensitive K channel activators and smooth muscle relaxants are used.

Anti-Inflammatory Agents And Methods For Their Preparation And Use

View page
US Patent:
20020182260, Dec 5, 2002
Filed:
Mar 11, 2002
Appl. No.:
10/096968
Inventors:
Vivien Mak - Palo Alto CA, US
Michael Francoeur - Cupertino CA, US
Charles Chavdarian - San Ramon CA, US
Thomas Parks - San Mateo CA, US
Jung-Chung Lee - Sunnyvale CA, US
Charles Lee - Union City CA, US
Assignee:
Cellegy Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K035/78
A61K035/12
US Classification:
424/522000, 424/776000
Abstract:
This invention provides concentrated inflammation modifiers obtained from various plant, animal, and mineral sources, and methods for the preparation of such concentrated inflammation modifiers. Also provided are methods of preventing and treating inflammation using the concentrated inflammation modifiers. The invention also provides methods of treating inflammation of the skin and mucosal membranes by administering compositions that contain concentrated inflammation modifiers as active ingredients. The methods are useful for treating inflammatory diseases, as well as for reducing or eliminating inflammation that results from transdermal delivery of a drug, or from cosmetics and skin care products. The concentrated inflammation modifiers and methods are also useful for enhancing wound healing and skin aging.

Compositions And Methods For The Treatment Of Anorectal Disorders

View page
US Patent:
20020187990, Dec 12, 2002
Filed:
Jul 17, 2002
Appl. No.:
10/198250
Inventors:
Thomas Parks - San Mateo CA, US
Vivien Mak - Palo Alto CA, US
Jung-Chung Lee - Sunnyvale CA, US
Charles Lee - Union City CA, US
Assignee:
Cellegy Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K031/655
A61K031/513
A61K031/137
A61K031/198
A61K031/21
US Classification:
514/269000, 514/150000, 514/509000, 514/565000, 514/652000
Abstract:
Compositions and methods for the treatment of anorectal disorders are provided in which certain combinations of NO donors, PDE inhibitors, superoxide (O) scavengers, -adrenergic agonists, cAMP-dependent protein kinase activators, -adrenergic antagonists, L-type Ca channel blockers, estrogens, ATP-sensitive K channel activators and smooth muscle relaxants are used.

Compounds And Methods For The Treatment Of Urogenital Disorders

View page
US Patent:
20020198136, Dec 26, 2002
Filed:
Mar 6, 2002
Appl. No.:
10/094409
Inventors:
Vivien Mak - Palo Alto CA, US
Stephen Grayson - San Rafael CA, US
Assignee:
Cellegy Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K031/56
A61K031/5513
US Classification:
514/001000, 514/221000, 514/178000, 514/182000
Abstract:
The present invention provides methods for treating a variety of urogenital disorders, such as, for example, vaginismus, dyspareunia, vulvodynia (including vulvar vestibulitis), interstitial cystitis, nonspecific urethriris (i.e., nonspecific pain and/or burning of the urinary tract) and sexual dysfunctions, such as, for example, female sexual arousal disorders and female sexual orgasmic disorders, using a variety of compounds, including, but not limited to, NO donors, calcium channel blockers, cholinergic modulators, -adrenergic receptor antagonists, -adrenergic receptor agonists, phosphodiesterase inhibitors, cAMP-dependent protein kinase activators (e.g., cAMP mimetics), superoxide scavengers, potassium channel activators, estrogen-like compounds, testosterone-like compounds, benzodiazepines, adrenergic nerve inhibitors, antidiarrheal agents, HMG-CoA reductase inhibitors, smooth muscle relaxants, adenosine receptor modulators, adenylyl cyclase activators, endothelin receptor antagonists, bisphosphonates and cGMP-dependent protein kinase activators (e.g., cGMP mimetics).

Semisolid Topical Hormonal Compositions And Methods For Treatment

View page
US Patent:
20030175329, Sep 18, 2003
Filed:
Oct 4, 2002
Appl. No.:
10/264850
Inventors:
Daniel Azarnoff - Hillsborough CA, US
Vivien Mak - Palo Alto CA, US
Assignee:
Cellegy Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K031/56
A61K009/70
G06F019/00
G01N033/48
G01N033/50
US Classification:
424/449000, 514/177000, 514/182000, 702/019000
Abstract:
Semisolid topical pharmaceutical compositions comprising a therapeutically effective amount of a mammalian hormone and an effective amount of a penetration enhancer and methods for their use are provided. The pharmaceutical compositions and methods for their use can provide blood or plasma levels of the administered hormone within a predetermined or normal range of hormone values. In particular embodiments, the hormone is testosterone or estrogen and the amount to be applied to the skin of the subject is determined according to the weight or body mass index of the subject. The topical composition can be formulated in solutions, creams, lotions, ointments, and gels.

Compounds And Methods For The Treatment Of Urogenital Disorders

View page
US Patent:
20060030622, Feb 9, 2006
Filed:
Sep 26, 2005
Appl. No.:
11/236096
Inventors:
Vivien Mak - Palo Alto CA, US
Stephen Grayson - San Rafael CA, US
Assignee:
Cellegy Pharmaceuticals, Inc. - Brisbane CA
International Classification:
A61K 31/5513
A61K 31/519
A61K 31/21
US Classification:
514509000, 514221000, 514252160, 514262100
Abstract:
The present invention provides methods for treating a variety of urogenital disorders, such as, for example, vaginismus, dyspareunia, vulvodynia (including vulvar vestibulitis), interstitial cystitis, nonspecific urethriris (i.e., nonspecific pain and/or burning of the urinary tract) and sexual dysfunctions, such as, for example, female sexual arousal disorders and female sexual orgasmic disorders, using a variety of compounds, including, but not limited to, NO donors, calcium channel blockers, cholinergic modulators, α-adrenergic receptor antagonists, β-adrenergic receptor agonists, phosphodiesterase inhibitors, cAMP-dependent protein kinase activators (e.g., cAMP mimetics), superoxide scavengers, potassium channel activators, estrogen-like compounds, testosterone-like compounds, benzodiazepines, adrenergic nerve inhibitors, antidiarrheal agents, HMG-CoA reductase inhibitors, smooth muscle relaxants, adenosine receptor modulators, adenylyl cyclase activators, endothelin receptor antagonists, bisphosphonates and cGMP-dependent protein kinase activators (e.g., cGMP mimetics).
Control profile
Vivien Mak from San Jose, CA, age ~48 Get Report